jte-451
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT03018509)
Timeline
Indications
Studied for
Mechanism of action
- Nuclear receptor ROR-gammaANTAGONIST
RORC antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jte-451
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03832738 | Phase 2 | Jan 17, 2019 | Akros |
| NCT03018509 | Phase 1 | Dec 1, 2016 | Akros |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Akros | For profit | 2 | 2 | 2 | 2016 |
1 organizations
Page 1 / 1